TSPO and Hepatic fibrosis: In this study, we found that the expression levels of hepatic TSPO, TGF-β1, PDGF-β, and TNF-α mRNAs were increased progressively by 6 weeks of CCl4 treatment (Fig. 5), at which time liver fibrosis had almost developed into cirrhosis.